PharmaLundensis AB (XSAT:PHAL) Other Current Receivables : kr0.30 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is PharmaLundensis AB Other Current Receivables?

PharmaLundensis AB's Other Current Receivables for the quarter that ended in Mar. 2025 was kr0.30 Mil.

PharmaLundensis AB's quarterly Other Current Receivables declined from Sep. 2024 (kr0.32 Mil) to Dec. 2024 (kr0.30 Mil) but then increased from Dec. 2024 (kr0.30 Mil) to Mar. 2025 (kr0.30 Mil).

PharmaLundensis AB's annual Other Current Receivables increased from Dec. 2022 (kr0.27 Mil) to Dec. 2023 (kr0.30 Mil) and increased from Dec. 2023 (kr0.30 Mil) to Dec. 2024 (kr0.30 Mil).

PharmaLundensis AB Other Current Receivables Historical Data

The historical data trend for PharmaLundensis AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaLundensis AB Other Current Receivables Chart

PharmaLundensis AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Receivables

Get a 7-Day Free Trial

0.22

0.21

0.27

0.30

PharmaLundensis AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Receivables	Get a 7-Day Free Trial															0.28	0.25	0.32	0.30	0.30

PharmaLundensis AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

PharmaLundensis AB Other Current Receivables Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaLundensis AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

PharmaLundensis AB, Scheelevagen 2, Lund, SWE, 223 63

Website

http://www.pharmalundensis.se

PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.

PharmaLundensis AB Headlines

No Headlines